Artificial oxygen carriers: Scientific and biotechnological points of view

Artificial Organs

Volumn 33, Issue 2, 2009, Pages 92-96

  Simoni, Jan ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL OXYGEN CARRIER;

OXYGEN;

BLOOD SUBSTITUTE; CYCLIC GMP; DIASPIRIN CROSSLINKED HEMOGLOBIN; DIPEPTIDYL CARBOXYPEPTIDASE; FLUOROCARBON; FLUOSOL DA; GLUTATHIONE; GUANYLATE CYCLASE; HEMOGLOBIN; HEMOZYME; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NITRIC OXIDE; OXYCYTE; POLYMERIZED HEMOGLOBIN; RECOMBINANT HEMOGLOBIN; UNCLASSIFIED DRUG;

ARTIFICIAL ORGAN; BIOTECHNOLOGY; BLOOD DONOR; BLOOD GROUP TYPING; BLOOD OXYGENATION; BLOOD STORAGE; BLOOD SUBSTITUTION; BLOOD TRANSFUSION; DRUG ACTIVITY; EDITORIAL; ERYTHROCYTE CONCENTRATE; HEART INFARCTION; HUMAN; NITROSYLATION; OXYGEN AFFINITY; PRIORITY JOURNAL; TRAUMATIC BRAIN INJURY; UNSPECIFIED SIDE EFFECT; VASOCONSTRICTION;

EID: 58849153330     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2008.00691.x     Document Type: Editorial

References (30)

1. Vamvakas EC, Taswell HF. Epidemiology of blood transfusion. Transfusion 1994 34 : 464 70.
2. Strauss RG. Blood banking issues pertaining to neonatal red blood cell transfusions. Transfus Sci 1999 21 : 7 19.
3. Murphy GJ, Reeves BC, Rogers CA, Rizvi SIA, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007 116 : 2544 52.
4. Winslow RM. Red cell substitutes. Semin Hematol 2007 44 : 51 9.
5. Riess JG. Oxygen carriers ("Blood Substitutes") - raison d'etre, chemistry and some physiology. Chem Rev 2001 101 : 2797 919.
6. Bassett P. Blood Substitutes, Selected Growth Factors, Stem cells and Hemoglobin Modifiers: Products, Markets and Opportunities. Drug & Market Development. Southborough, MA : International Business Communications, Inc., 1995. Report No. 907.
7. Winslow RM. Blood substitutes: science or business? J Lab Clin Med 1996 128 : 146 7.
8. Alayash AI. Hemoglobin-based blood substitutes: oxygen carriers, pressor agents, or oxidants? Nature Biotechnol 1999 17 : 545 9.
9. Winslow RM. Blood substitutes - a moving target. Nat Med 1995 1 : 1212 5.
10. Amberson WR. Blood substitutes. Biol Rev 1937 12 : 48 85.
11. Rinaldi A. A bloodless revolution. EMBO Rep 2005 6 : 705 8.
12. Benesch RE, Benesch R, Renthal RD, Maeda N. Affinity labeling of the polyphosphate binding site of hemoglobin. Biochemistry 1972 11 : 3576 82.
13. Chatterjee R, Welty EV, Walder RY, Walder JA. Isolation and characterization of a new hemoglobin derivative crosslinked between alpha chains (lysine 99 alpha 1-99 alpha 2). J Biol Chem 1986 261 : 9929 37.
14. Feola M, Simoni J, Canizaro PC, Tran R, Raschbaum G, Behal FJ. Toxicity of polymerized hemoglobin solutions. Surg Gyn Obstet 1988 166 : 211 22.
15. Hoffman SJ, Looker DL, Roehrich JM, et al. Expression of fully functional tetrameric human hemoglobin in E. Coli. Proc Natl Acad Sci 1990 87 : 8521 5.
16. Savitsky JP, Doczi J, Black J, Arnold JDA. Clinical safety trial of stroma-free hemoglobin. Clin Pharmacol Ther 1978 23 : 73 80.
17. Natanson C, Kern SJ, Lurie P, Banks SM, Wolfe SM. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta analysis. JAMA 2008 299 : 2304 12.
18. Fratantoni JC. Points to consider in the safety evaluation of hemoglobin-based oxygen carriers. Transfusion 1991 31 : 369 71.
19. Simoni J. Endothelial cell response to hemoglobin based oxygen carriers. Is the attenuation of pathological reactions possible? In : Kobayashi K, Tsuchida E, Horinouchi H, eds. Artificial Oxygen Carrier. Its Front Line. Tokyo : Springer-Verlag, 2005 75 125.
20. Nakagawa A, Komatsu T, Tsuchida E. Albumin-heme: human serum albumin based dioxygen carrier. Artif Organs 2007 31 : A40 (SY5-10).
21. Simoni J, Feola M, Simoni G, Moeller JF, Bollon A, Mittemeyer BT. Hemotech, a novel free Hb-based red cell substitute with pharmacological properties: current status of development. Artif Organs 2007 30 : A41 (SY5-15).
22. Briceno JC. Perfluorocarbon-based oxygen carriers: status of research and clinical perspectives. Artif Organs 2007 31 : A39 (SY5-5).
23. Fukushima S. PEG-perfluorocarbon emulsion and new high pressure homogenizer for preparation. Artif Organs 2007 31 : A39 (SY5-6).
24. D'Agnillo F, Chang TM. Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties. Nat Biotechnol 1998 16 : 667 71.
25. Saezler RK, Arfors KE, Tuma RF, et al. Polynitroxylated hemoglobin-based oxygen carrier: inhibition of free radical-induced microcirculatory dysfunction. Free Radic Biol Med 1999 27 : 1 6.
26. Wu B, Zhu X, Yan K, Dan N, Chen C. Functional and physiological characterization of glutaraldehyde-polymerized porcine hemoglobin. The XIth International Symposium on Blood Substitutes. Beijing, China, October 18-21, 2007. Abstract Book 2007;52(KL-8).
27. Lowe KC. Blood substitutes: from chemistry to clinic. J Mater Chem 2006 16 : 4189 96.
28. Mozzarelli A. Hemoglobin-based oxygen carriers as blood substitutes. Biochim Biophys Acta 2008 1784 : 1363 4.
29. Guidance for Industry. Criteria for Safety and Efficacy Evaluation of Oxygen Therapeutics as Red Blood Cell Substitutes. Draft Guidance. Rockville, MD : U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, 2004.
30. Public Workshop. Safety of Hemoglobin-Based Oxygen Carriers (HBOCs). Bethesda, MD : Center for Biologics Evaluation and Research, FDA, The National Heart, Lung and Blood Institute, NIH, and Office of the Secretary and Office of Public Health and Science, DHHS, 2008. April 29-30. Available at: http://www.fda.gov/cber/blood/hboc042908.htm. Accessed May 30, 2008.